The Global Near Infrared Imaging Market size is expected to reach $3.2 billion by 2030, rising at a market growth of 6.0% CAGR during the forecast period.
NIR imaging reagents are used in various industrial applications, such as quality control in manufacturing processes, food safety testing, and material characterization. Therefore, the reagents segment captured $1,204.2 million revenue in the market in 2022. Moreover, the increasing use of NIR imaging in medical diagnostics and research has driven the demand for NIR imaging reagents. These reagents play a crucial role in enhancing the sensitivity and specificity of NIR imaging techniques, particularly in applications such as fluorescence imaging and molecular imaging.
The major strategies followed by the market participants are Product launches as the key developmental strategy to keep pace with the changing demands of end users. For instance, In August, 2022, Shimadzu introduced the LuminousQuester NI near-infrared imaging system, which comprises dedicated software and a camera that is capable of concurrently imaging visible light and near-infrared light. The system records near-infrared light that is less interfered with indoor lighting and because of this imaging can be carried out in a vast range of testing environments. Additionally, In November, 2023, Olympus Corporation had announced the release of its next-generation EVIS X1™ endoscopy system in China, completing its availability in all major markets. The EVIS X1 is Olympus' most advanced endoscopy system. Olympus® GI endoscopy systems, including the EVIS X1, assisted physicians in diagnosing.
Based on the Analysis presented in the KBV Cardinal matrix; Leica Microsystems GmbH (Danaher Corporation) is the major forerunner in the Near Infrared Imaging Market. In April, 2020, Leica Microsystems introduced STELLARIS, a flagship new confocal microscopy platform. STELLARIS enhanced the capability of capturing three-dimensional images of living cells and tissues. The platform added a dimension of information to confocal imaging and provided access to lifetime-based information in every experiment. Companies such as Medtronic PLC, Stryker Corporation and Olympus Corporation are some of the key innovators in the Near Infrared Imaging Market.
COVID-19 Impact Analysis
The pandemic led to disruptions in global supply chains, affecting the production and distribution of NIR imaging devices and components. This disruption resulted in delays in product availability and increased costs for manufacturers. Many research institutions and companies redirected their resources toward COVID-19-related research, leading to reduced investment in non-essential areas such as NIR imaging technology development. This shift in focus slowed down innovation and product development in the market. Therefore, while the COVID-19 pandemic presented challenges for the NIR imaging market, it also created opportunities, especially in the healthcare sector where there was increased demand for imaging technologies.
Market Growth Factors
As the number of surgeries increases, there is a greater demand for imaging systems that can provide real-time, high-resolution imaging to aid surgeons in achieving greater precision during procedures. Moreover, the growing preference for minimally invasive surgical techniques, which require advanced imaging technologies for visualization, has led to an increased demand for NIR imaging systems. The frequency and incidence of a number of diseases, including cardiovascular diseases, cancer, neurovascular disorders, and gastrointestinal diseases, are on the rise, which is contributing to an increase in the number of surgical procedures performed. Additionally, some developing countries are becoming popular destinations for medical tourism due to lower costs and high-quality healthcare services. The demand for advanced imaging technologies like NIR systems is driven by the need to cater to the growing number of medical tourists seeking diagnostic and treatment services. Thus, the need for diverse imaging modalities, such as NIR imaging, has expanded in recent years as a direct result of the expansion of the life sciences research business, which will bolster the expansion of the market.
Market Restraining Factors
Stringent regulatory requirements for medical devices, including NIR imaging systems, can pose challenges for manufacturers, distributors, and healthcare providers. These hurdles may include lengthy approval processes, complex compliance standards, and high documentation requirements, all of which can delay the introduction of new products to the market. As a result, manufacturers may face increased costs and time-to-market for their NIR imaging systems, which can hinder innovation and limit the availability of advanced technologies for healthcare providers and patients. Furthermore, regulatory hurdles can impact the global competitiveness of NIR imaging technology. In regions with more relaxed regulatory environments, such as emerging markets, competing imaging technologies may gain a foothold more easily, potentially leading to disparities in access to advanced medical imaging technologies based on geographical location. Thus, all these challenges can create hurdles for manufacturers seeking to expand their market presence internationally and may limit the overall growth potential of the market.
By Product Analysis
Based on the product, the market is bifurcated into devices and reagents. The reagents segment dominated the revenue share in the near infrared imaging market in 2022. NIR imaging reagents are used in various industrial applications, such as quality control in manufacturing processes, food safety testing, and material characterization. Moreover, the increasing use of NIR imaging in medical diagnostics and research has driven the demand for NIR imaging reagents. These reagents play a crucial role in enhancing the sensitivity and specificity of NIR imaging techniques, particularly in applications such as fluorescence imaging and molecular imaging.
By Reagents Analysis
Based on the reagents type, the reagents segment is further fragmented into indocyanine green (ICG) and other reagents. The indocyanine green (ICG) segment witnessed the highest revenue share in the market in 2022. ICG is used in NIR imaging for vascular imaging and perfusion studies. It can be injected intravenously to assess blood flow dynamics, tissue perfusion, and vascular integrity in various medical specialties, including cardiology, neurology, and vascular surgery. In oncology, ICG is utilized for NIR imaging in cancer diagnosis and treatment. It can be conjugated with targeting moieties to specifically bind to cancer cells, allowing for the visualization of tumors and metastases. This application has driven the demand for ICG reagents in NIR imaging for cancer-related research and clinical use.
By Devices Analysis
On the basis of device type, the device segment of the market is segmented into near-infrared fluorescence imaging systems and near-infrared fluorescence & bioluminescence imaging systems. The near infrared fluorescence imaging systems segment recorded the largest revenue share in the market in 2022. The demand for NIR fluorescence imaging systems is driven by their ability to provide high-resolution, real-time imaging of tissues and structures, making them valuable tools in medical imaging, research, and clinical practice. The increase in the prevalence of gastrointestinal, cardiovascular, and cancer diseases are the main fields where these devices are widely employed. Additionally, the NIR fluorescence imaging systems help in the expedited discovery of functions associated with lymphatic systems. This is possible because of NIR's high sensitivity, which allows high temporal and spatial resolutions.
By Application Analysis
On the basis of application, the market is divided into preclinical imaging, cancer surgeries, gastrointestinal surgeries, cardiovascular surgeries, plastic/reconstructive surgeries, and other applications. The cardiovascular surgeries segment recorded a promising growth rate in the market in 2022. Cardiovascular diseases, including coronary artery disease, heart failure, and valvular heart disease, are among the leading causes of death worldwide. The high prevalence of these conditions drives the demand for cardiovascular surgeries as a treatment option to manage and treat these diseases. The aging population worldwide has led to an increase in the prevalence of age-related cardiovascular conditions, such as atherosclerosis and heart valve degeneration. As the population ages, there is a growing demand for cardiovascular surgeries to address these age-related conditions.
By End Use Analysis
Based on end-user, the market is categorized into hospitals & clinics, pharmaceutical & biotechnology companies, and research laboratories. The hospitals and clinics segment witnessed the highest revenue share in the market in 2022. The demand for NIR imaging systems in hospitals and clinics is driven by their versatility, non-invasive nature, and ability to provide real-time insights into biological processes. Near-infrared sensors built into laparoscopic instruments assist surgeons to prevent unintentional blood vessel rupture. The use of these technologies aids in reducing surgical errors, shortening hospital stays, and lowering patient healthcare expenses.
By Regional Analysis
On the basis of region, the near infrared imaging market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the largest revenue share in the market in 2022. North America has a significant healthcare expenditure, with a focus on advanced medical technologies and innovative treatments. The increasing investment in healthcare infrastructure and research and development activities drives the demand for advanced imaging systems like NIR for diagnostic and therapeutic applications. Additionally, a rise in reconstructive and cosmetic procedures in the nation as a result of higher spending and growing awareness of early diagnosis is anticipated to generate significant growth potential.
Recent Strategies Deployed in the Market
- Sep-2022: Olympus Corporation released VISERA ELITE III, which offers multiple imaging functions, all comprises in one system upgrading minimally invasive therapies such as Laparoscopic Cholecystectomy and Laparoscopic Colectomy. The system focuses on enhancing efficiency in the operating room, empowers the quality of endoscopic surgery, and builds up the standard of care.
- Jun-2022: Shimadzu announced the launch of iMScope QT Imaging Mass Microscope, a high-level mass spectrometry imaging analysis. The microscope comprises an AP-MALDI ion source, the Q-TOF LCMS-9030, and an optical microscope. This enables the recognition of molecules in a tissue region area immediately after microscopy. Combining with LCMS-9030 helps in obtaining quantitative data and distribution information for comprehensive analysis.
- Apr-2022: Medtronic came into collaboration with GE Healthcare, a manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals for imaging modalities. The collaboration was focused on demands and needs for care at Office-Based Labs (OBLs) and Ambulatory Surgery Centers (ASCs). With this collaboration, customers can access extensive financial solutions, product portfolios, and exceptional service and this would enhance clinical outcomes, workflow, and efficiency for ASCs and OBLs.
- Jul-2021: Hamamatsu Photonics opened a new factory building at Joko-Cho, Hamamatsu City, Japan. The expansion aims to strengthen the production capacity of the measurement and imaging instruments business. This expansion would enhance sales of measurement and imaging instruments such as digital slide scanners for pathology, semiconductor failure analysis systems, and digital cameras for scientific measurement.
- Jan-2021: KARL STORZ Endoscopy-America, Inc. unveiled The IMAGE1 S Rubina multimode visualization system, the latest addition to endoscopic imaging. The product comprises upgraded fluorescence-guided imaging with state-of-the-art 4K resolution applying indocyanine green dye (NIR/ICG) and near-infrared light. Rubina is designed with proprietary and unique dual-LED light technology and dual-4K sensors to switch between fluorescence and white-light modes, with the absence of mismatched or lag frames.
List of Key Companies Profiled
- Medtronic PLC
- Stryker Corporation
- Olympus Corporation
- Hamamatsu Photonics K.K.
- Carl Zeiss Meditec AG (Carl Zeiss AG)
- PerkinElmer, Inc.
- Leica Microsystems GmbH (Danaher Corporation)
- Shimadzu Corporation
- Karl Storz SE & Co. KG
- Fluoptics SAS
Global Near Infrared Imaging Market Report Segmentation
By Product
- Reagents
- Indocyanine Green (ICG)
- Others
- Devices
- Near-infrared Fluorescence Imaging Systems
- Near-infrared Fluorescence & Bioluminescence Imaging Systems
By Application
- Preclinical Imaging
- Cancer Surgeries
- Gastrointestinal Surgeries
- Cardiovascular Surgeries
- Plastic/Reconstructive Surgeries
- Others
By End User
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Research Laboratories
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Global Near Infrared Imaging Market, by Product
- 1.4.2 Global Near Infrared Imaging Market, by Application
- 1.4.3 Global Near Infrared Imaging Market, by End User
- 1.4.4 Global Near Infrared Imaging Market, by Geography
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.2.4 Approval
- 4.2.5 Geographical Expansion
- 4.2.6 Business Expansion
- 4.3 Top Winning Strategies
- 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
- 4.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2018, Sep - 2023, Nov) Leading Players
- 4.4 Porter Five Forces Analysis
Chapter 5. Global Near Infrared Imaging Market by Product
- 5.1 Global Reagents Market by Region
- 5.2 Global Near Infrared Imaging Market by Reagents Type
- 5.2.1 Global Indocyanine Green (ICG) Market by Region
- 5.2.2 Global Others Market by Region
- 5.3 Global Devices Market by Region
- 5.4 Global Near Infrared Imaging Market by Devices Type
- 5.4.1 Global Near-infrared Fluorescence Imaging Systems Market by Region
- 5.4.2 Global Near-infrared Fluorescence & Bioluminescence Imaging Systems Market by Region
Chapter 6. Global Near Infrared Imaging Market by Application
- 6.1 Global Preclinical Imaging Market by Region
- 6.2 Global Cancer Surgeries Market by Region
- 6.3 Global Gastrointestinal Surgeries Market by Region
- 6.4 Global Cardiovascular Surgeries Market by Region
- 6.5 Global Plastic/Reconstructive Surgeries Market by Region
- 6.6 Global Others Market by Region
Chapter 7. Global Near Infrared Imaging Market by End User
- 7.1 Global Hospitals & Clinics Market by Region
- 7.2 Global Pharmaceutical & Biotechnology Companies Market by Region
- 7.3 Global Research Laboratories Market by Region
Chapter 8. Global Near Infrared Imaging Market by Region
- 8.1 North America Near Infrared Imaging Market
- 8.1.1 North America Near Infrared Imaging Market by Product
- 8.1.1.1 North America Reagents Market by Region
- 8.1.1.2 North America Near Infrared Imaging Market by Reagents Type
- 8.1.1.2.1 North America Indocyanine Green (ICG) Market by Country
- 8.1.1.2.2 North America Others Market by Country
- 8.1.1.3 North America Devices Market by Region
- 8.1.1.4 North America Near Infrared Imaging Market by Devices Type
- 8.1.1.4.1 North America Near-infrared Fluorescence Imaging Systems Market by Country
- 8.1.1.4.2 North America Near-infrared Fluorescence & Bioluminescence Imaging Systems Market by Country
- 8.1.2 North America Near Infrared Imaging Market by Application
- 8.1.2.1 North America Preclinical Imaging Market by Country
- 8.1.2.2 North America Cancer Surgeries Market by Country
- 8.1.2.3 North America Gastrointestinal Surgeries Market by Country
- 8.1.2.4 North America Cardiovascular Surgeries Market by Country
- 8.1.2.5 North America Plastic/Reconstructive Surgeries Market by Country
- 8.1.2.6 North America Others Market by Country
- 8.1.3 North America Near Infrared Imaging Market by End User
- 8.1.3.1 North America Hospitals & Clinics Market by Country
- 8.1.3.2 North America Pharmaceutical & Biotechnology Companies Market by Country
- 8.1.3.3 North America Research Laboratories Market by Country
- 8.1.4 North America Near Infrared Imaging Market by Country
- 8.1.4.1 US Near Infrared Imaging Market
- 8.1.4.1.1 US Near Infrared Imaging Market by Product
- 8.1.4.1.2 US Near Infrared Imaging Market by Application
- 8.1.4.1.3 US Near Infrared Imaging Market by End User
- 8.1.4.2 Canada Near Infrared Imaging Market
- 8.1.4.2.1 Canada Near Infrared Imaging Market by Product
- 8.1.4.2.2 Canada Near Infrared Imaging Market by Application
- 8.1.4.2.3 Canada Near Infrared Imaging Market by End User
- 8.1.4.3 Mexico Near Infrared Imaging Market
- 8.1.4.3.1 Mexico Near Infrared Imaging Market by Product
- 8.1.4.3.2 Mexico Near Infrared Imaging Market by Application
- 8.1.4.3.3 Mexico Near Infrared Imaging Market by End User
- 8.1.4.4 Rest of North America Near Infrared Imaging Market
- 8.1.4.4.1 Rest of North America Near Infrared Imaging Market by Product
- 8.1.4.4.2 Rest of North America Near Infrared Imaging Market by Application
- 8.1.4.4.3 Rest of North America Near Infrared Imaging Market by End User
- 8.2 Europe Near Infrared Imaging Market
- 8.2.1 Europe Near Infrared Imaging Market by Product
- 8.2.1.1 Europe Reagents Market by Country
- 8.2.1.2 Europe Near Infrared Imaging Market by Reagents Type
- 8.2.1.2.1 Europe Indocyanine Green (ICG) Market by Country
- 8.2.1.2.2 Europe Others Market by Country
- 8.2.1.3 Europe Devices Market by Country
- 8.2.1.4 Europe Near Infrared Imaging Market by Devices Type
- 8.2.1.4.1 Europe Near-infrared Fluorescence Imaging Systems Market by Country
- 8.2.1.4.2 Europe Near-infrared Fluorescence & Bioluminescence Imaging Systems Market by Country
- 8.2.2 Europe Near Infrared Imaging Market by Application
- 8.2.2.1 Europe Preclinical Imaging Market by Country
- 8.2.2.2 Europe Cancer Surgeries Market by Country
- 8.2.2.3 Europe Gastrointestinal Surgeries Market by Country
- 8.2.2.4 Europe Cardiovascular Surgeries Market by Country
- 8.2.2.5 Europe Plastic/Reconstructive Surgeries Market by Country
- 8.2.2.6 Europe Others Market by Country
- 8.2.3 Europe Near Infrared Imaging Market by End User
- 8.2.3.1 Europe Hospitals & Clinics Market by Country
- 8.2.3.2 Europe Pharmaceutical & Biotechnology Companies Market by Country
- 8.2.3.3 Europe Research Laboratories Market by Country
- 8.2.4 Europe Near Infrared Imaging Market by Country
- 8.2.4.1 Germany Near Infrared Imaging Market
- 8.2.4.1.1 Germany Near Infrared Imaging Market by Product
- 8.2.4.1.2 Germany Near Infrared Imaging Market by Application
- 8.2.4.1.3 Germany Near Infrared Imaging Market by End User
- 8.2.4.2 UK Near Infrared Imaging Market
- 8.2.4.2.1 UK Near Infrared Imaging Market by Product
- 8.2.4.2.2 UK Near Infrared Imaging Market by Application
- 8.2.4.2.3 UK Near Infrared Imaging Market by End User
- 8.2.4.3 France Near Infrared Imaging Market
- 8.2.4.3.1 France Near Infrared Imaging Market by Product
- 8.2.4.3.2 France Near Infrared Imaging Market by Application
- 8.2.4.3.3 France Near Infrared Imaging Market by End User
- 8.2.4.4 Russia Near Infrared Imaging Market
- 8.2.4.4.1 Russia Near Infrared Imaging Market by Product
- 8.2.4.4.2 Russia Near Infrared Imaging Market by Application
- 8.2.4.4.3 Russia Near Infrared Imaging Market by End User
- 8.2.4.5 Spain Near Infrared Imaging Market
- 8.2.4.5.1 Spain Near Infrared Imaging Market by Product
- 8.2.4.5.2 Spain Near Infrared Imaging Market by Application
- 8.2.4.5.3 Spain Near Infrared Imaging Market by End User
- 8.2.4.6 Italy Near Infrared Imaging Market
- 8.2.4.6.1 Italy Near Infrared Imaging Market by Product
- 8.2.4.6.2 Italy Near Infrared Imaging Market by Application
- 8.2.4.6.3 Italy Near Infrared Imaging Market by End User
- 8.2.4.7 Rest of Europe Near Infrared Imaging Market
- 8.2.4.7.1 Rest of Europe Near Infrared Imaging Market by Product
- 8.2.4.7.2 Rest of Europe Near Infrared Imaging Market by Application
- 8.2.4.7.3 Rest of Europe Near Infrared Imaging Market by End User
- 8.3 Asia Pacific Near Infrared Imaging Market
- 8.3.1 Asia Pacific Near Infrared Imaging Market by Product
- 8.3.1.1 Asia Pacific Reagents Market by Country
- 8.3.1.2 Asia Pacific Near Infrared Imaging Market by Reagents Type
- 8.3.1.2.1 Asia Pacific Indocyanine Green (ICG) Market by Country
- 8.3.1.2.2 Asia Pacific Others Market by Country
- 8.3.1.3 Asia Pacific Devices Market by Country
- 8.3.1.4 Asia Pacific Near Infrared Imaging Market by Devices Type
- 8.3.1.4.1 Asia Pacific Near-infrared Fluorescence Imaging Systems Market by Country
- 8.3.1.4.2 Asia Pacific Near-infrared Fluorescence & Bioluminescence Imaging Systems Market by Country
- 8.3.2 Asia Pacific Near Infrared Imaging Market by Application
- 8.3.2.1 Asia Pacific Preclinical Imaging Market by Country
- 8.3.2.2 Asia Pacific Cancer Surgeries Market by Country
- 8.3.2.3 Asia Pacific Gastrointestinal Surgeries Market by Country
- 8.3.2.4 Asia Pacific Cardiovascular Surgeries Market by Country
- 8.3.2.5 Asia Pacific Plastic/Reconstructive Surgeries Market by Country
- 8.3.2.6 Asia Pacific Others Market by Country
- 8.3.3 Asia Pacific Near Infrared Imaging Market by End User
- 8.3.3.1 Asia Pacific Hospitals & Clinics Market by Country
- 8.3.3.2 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
- 8.3.3.3 Asia Pacific Research Laboratories Market by Country
- 8.3.4 Asia Pacific Near Infrared Imaging Market by Country
- 8.3.4.1 China Near Infrared Imaging Market
- 8.3.4.1.1 China Near Infrared Imaging Market by Product
- 8.3.4.1.2 China Near Infrared Imaging Market by Application
- 8.3.4.1.3 China Near Infrared Imaging Market by End User
- 8.3.4.2 Japan Near Infrared Imaging Market
- 8.3.4.2.1 Japan Near Infrared Imaging Market by Product
- 8.3.4.2.2 Japan Near Infrared Imaging Market by Application
- 8.3.4.2.3 Japan Near Infrared Imaging Market by End User
- 8.3.4.3 India Near Infrared Imaging Market
- 8.3.4.3.1 India Near Infrared Imaging Market by Product
- 8.3.4.3.2 India Near Infrared Imaging Market by Application
- 8.3.4.3.3 India Near Infrared Imaging Market by End User
- 8.3.4.4 South Korea Near Infrared Imaging Market
- 8.3.4.4.1 South Korea Near Infrared Imaging Market by Product
- 8.3.4.4.2 South Korea Near Infrared Imaging Market by Application
- 8.3.4.4.3 South Korea Near Infrared Imaging Market by End User
- 8.3.4.5 Singapore Near Infrared Imaging Market
- 8.3.4.5.1 Singapore Near Infrared Imaging Market by Product
- 8.3.4.5.2 Singapore Near Infrared Imaging Market by Application
- 8.3.4.5.3 Singapore Near Infrared Imaging Market by End User
- 8.3.4.6 Malaysia Near Infrared Imaging Market
- 8.3.4.6.1 Malaysia Near Infrared Imaging Market by Product
- 8.3.4.6.2 Malaysia Near Infrared Imaging Market by Application
- 8.3.4.6.3 Malaysia Near Infrared Imaging Market by End User
- 8.3.4.7 Rest of Asia Pacific Near Infrared Imaging Market
- 8.3.4.7.1 Rest of Asia Pacific Near Infrared Imaging Market by Product
- 8.3.4.7.2 Rest of Asia Pacific Near Infrared Imaging Market by Application
- 8.3.4.7.3 Rest of Asia Pacific Near Infrared Imaging Market by End User
- 8.4 LAMEA Near Infrared Imaging Market
- 8.4.1 LAMEA Near Infrared Imaging Market by Product
- 8.4.1.1 LAMEA Reagents Market by Country
- 8.4.1.2 LAMEA Near Infrared Imaging Market by Reagents Type
- 8.4.1.2.1 LAMEA Indocyanine Green (ICG) Market by Country
- 8.4.1.2.2 LAMEA Others Market by Country
- 8.4.1.3 LAMEA Devices Market by Country
- 8.4.1.4 LAMEA Near Infrared Imaging Market by Devices Type
- 8.4.1.4.1 LAMEA Near-infrared Fluorescence Imaging Systems Market by Country
- 8.4.1.4.2 LAMEA Near-infrared Fluorescence & Bioluminescence Imaging Systems Market by Country
- 8.4.2 LAMEA Near Infrared Imaging Market by Application
- 8.4.2.1 LAMEA Preclinical Imaging Market by Country
- 8.4.2.2 LAMEA Cancer Surgeries Market by Country
- 8.4.2.3 LAMEA Gastrointestinal Surgeries Market by Country
- 8.4.2.4 LAMEA Cardiovascular Surgeries Market by Country
- 8.4.2.5 LAMEA Plastic/Reconstructive Surgeries Market by Country
- 8.4.2.6 LAMEA Others Market by Country
- 8.4.3 LAMEA Near Infrared Imaging Market by End User
- 8.4.3.1 LAMEA Hospitals & Clinics Market by Country
- 8.4.3.2 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
- 8.4.3.3 LAMEA Research Laboratories Market by Country
- 8.4.4 LAMEA Near Infrared Imaging Market by Country
- 8.4.4.1 Brazil Near Infrared Imaging Market
- 8.4.4.1.1 Brazil Near Infrared Imaging Market by Product
- 8.4.4.1.2 Brazil Near Infrared Imaging Market by Application
- 8.4.4.1.3 Brazil Near Infrared Imaging Market by End User
- 8.4.4.2 Argentina Near Infrared Imaging Market
- 8.4.4.2.1 Argentina Near Infrared Imaging Market by Product
- 8.4.4.2.2 Argentina Near Infrared Imaging Market by Application
- 8.4.4.2.3 Argentina Near Infrared Imaging Market by End User
- 8.4.4.3 UAE Near Infrared Imaging Market
- 8.4.4.3.1 UAE Near Infrared Imaging Market by Product
- 8.4.4.3.2 UAE Near Infrared Imaging Market by Application
- 8.4.4.3.3 UAE Near Infrared Imaging Market by End User
- 8.4.4.4 Saudi Arabia Near Infrared Imaging Market
- 8.4.4.4.1 Saudi Arabia Near Infrared Imaging Market by Product
- 8.4.4.4.2 Saudi Arabia Near Infrared Imaging Market by Application
- 8.4.4.4.3 Saudi Arabia Near Infrared Imaging Market by End User
- 8.4.4.5 South Africa Near Infrared Imaging Market
- 8.4.4.5.1 South Africa Near Infrared Imaging Market by Product
- 8.4.4.5.2 South Africa Near Infrared Imaging Market by Application
- 8.4.4.5.3 South Africa Near Infrared Imaging Market by End User
- 8.4.4.6 Nigeria Near Infrared Imaging Market
- 8.4.4.6.1 Nigeria Near Infrared Imaging Market by Product
- 8.4.4.6.2 Nigeria Near Infrared Imaging Market by Application
- 8.4.4.6.3 Nigeria Near Infrared Imaging Market by End User
- 8.4.4.7 Rest of LAMEA Near Infrared Imaging Market
- 8.4.4.7.1 Rest of LAMEA Near Infrared Imaging Market by Product
- 8.4.4.7.2 Rest of LAMEA Near Infrared Imaging Market by Application
- 8.4.4.7.3 Rest of LAMEA Near Infrared Imaging Market by End User
Chapter 9. Company Profiles
- 9.1 Medtronic PLC
- 9.1.1 Company overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Partnerships, Collaborations, and Agreements:
- 9.1.5.2 Product Launches and Product Expansions:
- 9.1.5.3 Approvals & Trails:
- 9.1.6 SWOT Analysis
- 9.2 Stryker Corporation
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Product Launches and Product Expansions:
- 9.2.5.2 Acquisition and Mergers:
- 9.2.6 SWOT Analysis
- 9.3 Olympus Corporation
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Recent strategies and developments:
- 9.3.4.1 Partnerships, Collaborations, and Agreements:
- 9.3.4.2 Product Launches and Product Expansions:
- 9.3.5 SWOT Analysis
- 9.4 Hamamatsu Photonics K.K.
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 Recent strategies and developments:
- 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.5.2 Product Launches and Product Expansions:
- 9.4.5.3 Geographical Expansions:
- 9.4.6 SWOT Analysis
- 9.5 Carl Zeiss Meditec AG (Carl Zeiss AG)
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Product Launches and Product Expansions:
- 9.5.6 SWOT Analysis
- 9.6 PerkinElmer, Inc. (Revvity, Inc)
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expense
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Product Launches and Product Expansions:
- 9.6.5.2 Business Expansion:
- 9.6.6 SWOT Analysis
- 9.7 Leica Microsystems GmbH (Danaher Corporation)
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expense
- 9.7.5 Recent strategies and developments:
- 9.7.5.1 Product Launches and Product Expansions:
- 9.7.5.2 Partnerships, Collaborations, and Agreements:
- 9.7.5.3 Acquisitions and Mergers:
- 9.7.6 SWOT Analysis
- 9.8 Shimadzu Corporation
- 9.8.1 Company Overview
- 9.8.2 Segmental and Regional Analysis
- 9.8.3 Research & Development Expense
- 9.8.4 Recent strategies and developments:
- 9.8.4.1 Product Launches and Product Expansions:
- 9.8.4.2 Partnerships, Collaborations, and Agreements:
- 9.8.5 SWOT Analysis
- 9.9 Karl Storz SE & Co. KG
- 9.9.1 Company Overview
- 9.9.2 Recent strategies and developments:
- 9.9.2.1 Product Launches and Product Expansions:
- 9.9.3 SWOT Analysis
- 9.10. Fluoptics SAS (Getinge AB)
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expense
- 9.10.5 SWOT Analysis
- 9.11 Mizuho Medical Co., Ltd.
Chapter 10. Winning imperatives of Near Infrared Imaging Market